Daily non-political popular news in brief.

How 'IAP antagonist' chemicals kill tumors

Chemical compounds specially designed to neutralize proteins that would otherwise allow tumor cells to cheat death have been recognized for some time by scientists as a promising new avenue for cancer therapy. Now, two studies in the Nov. 16, 2007 issue of the journal Cell, a publication of Cell Press, provide insight into just how these antagonists of the anti-death -- so-called Inhibitor-of-Apoptosis (IAP) -- proteins work to fight tumors.

Read more »

Keywords: iap, antagonist, chemicals, kill, tumors, chemical, tumor

« Previous | Next »

Similar news on "How 'IAP antagonist' chemicals kill tumors":

1. Blood-vessel blocker aids cancer-killing virus
   11-27-2007 · EurekAlert!
   Cancer-killing viruses are a promising therapy for incurable brain tumors, but their effectiveness has been limited in part because immune cells rapidly eliminate them. That immune response might be slowed, and the virus given more time to kill cancer cells, by blocking the growth of blood vessels in the tumor, new Ohio State research suggests. The study indicates that pretreatment with a drug that blocks blood-vessel growth might improve the effectiveness of cancer-killing viruses.
   Similar news · Read more »
   
2. Grape seed extract halts cell cycle, checking growth of colorectal tumors in mice
   10-18-2006 · EurekAlert!
   Chemicals found in grape seeds significantly inhibited growth of colorectal tumors in both cell cultures and in mice, according to researchers who have already demonstrated the extract's anti-cancer effects in other tumor types.
   Similar news · Read more »
   
3. Therapeutic peptide frees the protein p73 to kill tumor cells
   03-08-2007 · EurekAlert!
   p53 suppresses tumor development by inducing tumor cell death. However, targeting p53 for the treatment of cancer is confounded by the fact that genetic mutations cause loss or inactivation of p53 in approximately 50 percent of human cancers. Now, a new study indicates that targeting the p53-related protein p73 in mice induces the regression of established tumors of human origin, leading to the suggestion that p73 might be a viable target for developing anticancer therapeutics.
   Similar news · Read more »
   
4. Treatment capitalizes on unique qualities of radioisotope to prolong lives of brain tumor patients
   01-30-2008 · EurekAlert!
   In a study to determine safe dosages of the isotope astatine-211 for patients with recurring brain tumors, researchers were pleasantly surprised to find that not only was the isotope's potency sufficient to kill residual cancer cells without damaging sensitive healthy brain cells, but the patients experienced longer survival rates.
   Similar news · Read more »
   
5. The abortion pill compound prevents breast tumor growth
   11-30-2006 · EurekAlert!
   The chemical compound for the abortion pill has been found to prevent the growth of mammary tumors caused by the mutant gene responsible for a majority of breast and ovarian cancers, according to UC Irvine scientists.
   Similar news · Read more »
   
6. Holographic images use shimmer to show cellular response to anticancer drug
   03-06-2007 · EurekAlert!
   The response of tumors to anticancer drugs has been observed in real-time 3-D images using technology developed at Purdue University. The new digital holographic imaging system uses a laser and the same microchip used in household digital cameras, to see inside tumor cells. The device also may have applications in drug development and medical imaging.
   Similar news · Read more »
   
7. Cryoablation -- A new treatment option for some kidney tumor patients
   03-28-2007 · EurekAlert!
   Mayo Clinic researchers report that freezing kidney tumors through percutaneous cryoablation shows promise for patients who are not good candidates for surgery.
   Similar news · Read more »
   
8. Experimental drug shows promise in advanced kidney cancer
   09-26-2007 · EurekAlert!
   A new drug has shown promise in patients with advanced kidney cancer whose options run out after their tumor fails to respond to the cutting edge therapy. The study, presented today at the European Cancer Conference in Barcelona, showed that the experimental drug, axitinib, shrank tumors and delayed progression of the disease in a group of patients who are among the toughest to treat.
   Similar news · Read more »
   
9. Study suggests existing drugs may be useful in treating brain tumors
   10-15-2007 · EurekAlert!
   Scientists have shown how developing brain tumors can turn an encounter with a signaling molecule from a fatal experience for the tumor cells into a cue for their own growth and multiplication. The transformation relies on two molecules that can be modified with existing drugs, opening the possibility of using them to treat brain tumors.
   Similar news · Read more »
   
10. Serum carcinoembryonic antigen level can reflect adrenal adenoma
    11-21-2007 · EurekAlert!
    Serum carcinoembryonic antigen level is widely used as a reliable tumor marker in cancer patients. Previous reports have demonstrated that CEA level is rarely elevated in benign disease, and to our knowledge there have been no reports of CEA-producing benign adrenal tumors. Recently, Dr. Hori and colleagues presented the first case of carcinoembryonic antigen-producing adrenal adenoma, and discussed their techniques of laparoscopic surgery.
    Similar news · Read more »